EPA:ALTUV - Euronext Paris - Matif - FR0013345493 - Common Stock - Currency: EUR
EPA:ALTUV (6/27/2025, 7:00:00 PM)
1.894
-0.01 (-0.63%)
The current stock price of ALTUV.PA is 1.894 EUR. In the past month the price decreased by -8.06%. In the past year, price decreased by -14.68%.
Symbol | Company Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
PAR.DE | PARKER HANNIFIN CORP | 26.5 | 76.57B | ||
1ATCA.MI | ATLAS COPCO AB-A SHS | 25.02 | 67.68B | ||
ILT.DE | ILLINOIS TOOL WORKS | 24.39 | 61.74B | ||
TOM.OL | TOMRA SYSTEMS ASA | 37.12 | 45.38B | ||
SHR.DE | SCHINDLER HOLDING AG-REG | 28.76 | 32.12B | ||
XY6.DE | XYLEM INC | 29.19 | 26.78B | ||
1KNEBV.MI | KONE OYJ-B | 28.33 | 23.88B | ||
AUTO.OL | AUTOSTORE HOLDINGS LTD | 11.88 | 20.37B | ||
19V.DE | VAT GROUP AG | 47.54 | 10.72B | ||
G1A.DE | GEA GROUP AG | 22.24 | 9.70B | ||
RAA.DE | RATIONAL AG | 32.82 | 8.24B | ||
AZ2.DE | ANDRITZ AG | 12.9 | 6.52B |
Bio-UV Group SA engages in the design, manufacture, and market of ultraviolet light water treatment equipment. The company is headquartered in Lunel, Occitanie. The company went IPO on 2018-07-10. The firm designs, manufactures and markets systems and concepts of disinfection by ultraviolet light (UV-C) adapted to a number of applications, which enable automatic chlorine-free treatment for residential and collective swimming pools and spas. Bio-Uv Group SAS divides its range of products into two main segments: Individual, which includes residential pools & spas, fish ponds and aquariums and domestic drinking water for human consumption, and Professionals, which includes commercial pools and spas for professionals, water treatment, ballast water treatment, aquaculture, aquariums and fountains, among others.
BIO-UV GROUP SAS
850 Avenue Louis Medard
Lunel OCCITANIE FR
Employees: 155
Phone: 33499133911
The current stock price of ALTUV.PA is 1.894 EUR. The price decreased by -0.63% in the last trading session.
The exchange symbol of BIO-UV GROUP SAS is ALTUV and it is listed on the Euronext Paris - Matif exchange.
ALTUV.PA stock is listed on the Euronext Paris - Matif exchange.
9 analysts have analysed ALTUV.PA and the average price target is 3.06 EUR. This implies a price increase of 61.56% is expected in the next year compared to the current price of 1.894. Check the BIO-UV GROUP SAS stock analysts ratings, price target forecast and up-and down grades for more detailed information.
BIO-UV GROUP SAS (ALTUV.PA) has a market capitalization of 26.80M EUR. This makes ALTUV.PA a Nano Cap stock.
BIO-UV GROUP SAS (ALTUV.PA) currently has 155 employees.
BIO-UV GROUP SAS (ALTUV.PA) has a support level at 1.69 and a resistance level at 1.9. Check the full technical report for a detailed analysis of ALTUV.PA support and resistance levels.
The Revenue of BIO-UV GROUP SAS (ALTUV.PA) is expected to grow by 13.89% in the next year. Check the estimates tab for more information on the ALTUV.PA EPS, Sales, EBIT and EBITDA future analyst estimates.
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
BIO-UV GROUP SAS (ALTUV.PA) has a dividend yield of 2.5%. The yearly dividend amount is currently 0.06. Check the full fundamental report for a detailed analysis of ALTUV.PA dividend history, reliability and sustainability.
BIO-UV GROUP SAS (ALTUV.PA) will report earnings on 2025-09-17.
ChartMill assigns a technical rating of 1 / 10 to ALTUV.PA. When comparing the yearly performance of all stocks, ALTUV.PA is a bad performer in the overall market: 85.36% of all stocks are doing better.
ChartMill assigns a fundamental rating of 4 / 10 to ALTUV.PA. Both the profitability and financial health of ALTUV.PA have multiple concerns.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | 0.08% | ||
ROA | 0.05% | ||
ROE | 0.1% | ||
Debt/Equity | 0.57 |
ChartMill assigns a Buy % Consensus number of 87% to ALTUV.PA. The Buy consensus is the average rating of analysts ratings from 9 analysts.
For the next year, analysts expect an EPS growth of 99.99% and a revenue growth 13.89% for ALTUV.PA